Avantor Q2 Revenue Tops Estimates
Avantor (NYSE:AVTR), a major supplier of products and services for the life sciences, advanced technologies, and applied materials industries, reported results for Q2 2025 on August 1, 2025. The most notable news from this earnings release was a mixed outcome: GAAP revenue came in ahead of analyst expectations, while several profitability measures, including non-GAAP earnings per share (EPS), missed consensus estimates. It posted GAAP revenue of $1,683.4 million versus the analyst estimate of $1,674.6 million, and non-GAAP EPS of $0.24, falling shy of the $0.25 expectation. The quarter showed stable sequential trends in some end markets, but continued pressure on margins and cash flow. Management flagged ongoing operational and competitive pressures, and signaled a pending CEO transition.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Avantor is a global company that provides materials, consumables, equipment, and services to scientific and manufacturing customers. Its portfolio spans essential chemicals, laboratory supplies, production ingredients, equipment, and tailored logistics, all supporting customers in research, diagnostics, and complex manufacturing environments.
Source Fool.com
